Use of meloxicam for the long term-treatment of kidney disorders in cats
AssigneeBoehringer Ingelheim Vetmedica GmbH
InventorLaura JOHNSTON
Life of this patent
Estimating the term…
Abstract
The invention is directed to a formulation containing NSAIDs or a pharmacologically acceptable salt thereof of and one or more vehicles for the treatment of kidney diseases in cats. Serum creatinine concentrations increase less over time following treatment with NSAID compared to untreated cats.
Claims25
Non-steroidal anti-inflammatory drug (NSAID) or a pharmacologically acceptable salt thereof for use in the treatment of chronic kidney diseases in cats.
A non-steroidal anti-inflammatory drug or a pharmacologically acceptable salt thereof for use in the treatment of kidney diseases in cats.
A formulation containing a NSAID or a pharmacologically acceptable salt thereof for the treatment of chronic kidney diseases in cats, wherein said formulation essentially consists of a non-steroidal anti-inflammatory drug, water, optionally one or more additives selected from the group consisting of buffers, pH adjusters, solubilizers, preservatives and optionally thickeners.
A method of treating kidney disease in cats comprising administering an effective amount of a non-steroidal anti-inflammatory drug (NSAID) or a pharmacologically acceptable salt to a cat in need of said treatment.
Dependencies are inferred from the claim text.